Euler Biologics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Euler Biologics General Information

Description

Developer of antibody-based biologic therapies intended to preserve physical function in aging populations. The company's platform applies antibody engineering and targeted biological mechanisms to maintain muscle strength, mobility, and functional capacity over time by addressing age-related physiological decline and supporting resilience in physical systems, enabling healthcare providers and older adults to sustain independence, reduce reliance on long-term care, and better manage the societal impact of aging demographics.

Contact Information

Website
www.euler.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Euler Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 30-Sep-2024 Completed Startup
To view Euler Biologics’s complete valuation and funding history, request access »

Euler Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axial (San Francisco) Venture Capital Minority
Gaingels Venture Capital Minority
Pillar VC Venture Capital Minority
Soma Capital Venture Capital Minority
To view Euler Biologics’s complete investors history, request access »

Ready to get started?

Request a free trial

Euler Biologics FAQs

  • When was Euler Biologics founded?

    Euler Biologics was founded in 2024.

  • Where is Euler Biologics headquartered?

    Euler Biologics is headquartered in San Francisco, CA.

  • What industry is Euler Biologics in?

    Euler Biologics’s primary industry is Biotechnology.

  • Is Euler Biologics a private or public company?

    Euler Biologics is a Private company.

  • What is Euler Biologics’s current revenue?

    The current revenue for Euler Biologics is .

  • Who are Euler Biologics’s investors?

    Axial (San Francisco), Gaingels, Pillar VC, and Soma Capital have invested in Euler Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process